Illumina Plans Suite of Focused Genotyping Chips, Sees Slight Delay in 'Resurgence' of GWAS Market | GenomeWeb

By Justin Petrone

Illumina is preparing to launch more focused whole-genome genotyping arrays for use in genome-wide association studies, even as it gathers content for its next major BeadChip release, the Omni5, which is scheduled to launch next year.

Chief Financial Officer Christian Henry said this week that adoption of the firm's HumanOmni2.5-Quad DNA Analysis BeadChip is "ahead of expectations," and that its customers are "converting to the 2.5M from the 1M and other legacy products."

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

In PNAS this week: genes involved in histone deacetylation in Arabidopsis, effects of pathogenic presenilin-1 mutations, and more.

After a study finds DNA from antibiotic-resistant bacteria in Beijing smog, residents there worry, according to the New York Times.

Canada begins its search for a chief government science advisor, Nature News reports.

A company is using facial recognition tools to identify genetic disorders from pictures, Technology Review reports.